Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke

Cell Death and Differentiation

Volumn 8, Issue 7, 2001, Pages 679-686

  Martin Villalba, A ^a,b   Hahne, M ^c   Kleber, S ^b   Vogel, J ^b   Falk, W ^d   Schenkel, J ^b   Krammer, P H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Apoptosis; CD95 ligand; Gld; Stroke; Stroke therapy; TNF; Tnf ko

Indexed keywords

FAS LIGAND; GLUCOSE; NEUTRALIZING ANTIBODY; OXYGEN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; HEMISPHERE; HYBRID; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; LOCOMOTION; MORTALITY; MOUSE; MOUSE STRAIN; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; STROKE;

ANIMALS; ANTIBODIES; APOPTOSIS; BRAIN ISCHEMIA; CELLS, CULTURED; CEREBROVASCULAR ACCIDENT; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0034915133     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400882     Document Type: Article

References (53)

1. Stroke in the developing world
2. The concept of the therapeutic window: A synthesis of critical issues
3. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats
4. A novel protein domain required for apoptosis
5. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen
6. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins
7. A novel domain within the 55 kd TNF receptor signals cell death
8. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor
9. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC)
10. Two CD95 (APO-1/Fas) signaling pathways
11. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia
12. Expression of tumor necrosis factor apha after focal cerebral ischemia in the rat
13. Tumor necrosis factor α expression in ischemic neurons
14. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons
15. Localization of Fas antigen mRNA induced in postischemic murine forebrain by in situ hybridization
16. Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain
17. Neuroprotective effects of TNF binding protein in focal cerebral ischemia
18. Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia
19. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury
20. Inhibition of TNFχ attenuates infarct volume and ICAM-1 expression in ischemic mouse brain
21. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors
22. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor
23. TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice
24. TNF-alpha and IFN-gamma render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xL
25. Oxygen or glucose deprivation-induced neuronal injury in cortical cell cultures is reduced by tetanus toxin
26. Characterization of tumor necrosis factor-deficient mice
27. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease
28. Poly (ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia
29. Microvascular responses to cerebral ischemia/inflammation
30. Antitumor effect of locally produced CD95 ligand
31. Regulation of the proinflammatory effects of Fas ligand (CD95L)
32. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology
33. Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats
34. Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets
35. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death
36. T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB
37. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma
38. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis
39. Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-Chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines
40. Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival
41. Transient blood-brain barrier permeability following profound temporary global ischaemia: An experimental study using 14C-AIB
42. Disruption of the blood-cerebrospinal fluid barrier by transient cerebral ischemia
43. Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia
44. Inflammation and glial responses in ischemic brain lesions
45. Inhibition of tumor-induced migration of bovine capillary endothelial cells by mouse and rabbit tumor necrosis factor
46. Deficiency of intercellular adhesion molecule 1 attenuates microcirculatory disturbance and infarction size in focal cerebral ischemia
47. CD18-mediated neutrophil recruitment contributes to the pathogenesis of reperfused but not nonreperfused stroke
48. Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy
49. Early delineation of ischemic tissue in rat brain cryosections by high-contrast staining
50. Procedural and strain-related variables significantly affect outcome in a murine model of focal cerebral ischemia
51. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis
52. NF-kappaB is activated and promotes cell death in focal cerebral ischemia
53. Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape